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METHODOLOGY ARTICLE

Open Access

FastCloning: a highly simplified, purification-free,
sequence- and ligation-independent PCR cloning
method
Chaokun Li1, Aiyun Wen1, Benchang Shen1,3, Jia Lu2, Yao Huang2 and Yongchang Chang1*

Abstract
Background: Although a variety of methods and expensive kits are available, molecular cloning can be a timeconsuming and frustrating process.
Results: Here we report a highly simplified, reliable, and efficient PCR-based cloning technique to insert any DNA
fragment into a plasmid vector or into a gene (cDNA) in a vector at any desired position. With this method, the
vector and insert are PCR amplified separately, with only 18 cycles, using a high fidelity DNA polymerase. The
amplified insert has the ends with ~16-base overlapping with the ends of the amplified vector. After DpnI
digestion of the mixture of the amplified vector and insert to eliminate the DNA templates used in PCR reactions,
the mixture is directly transformed into competent E. coli cells to obtain the desired clones. This technique has
many advantages over other cloning methods. First, it does not need gel purification of the PCR product or
linearized vector. Second, there is no need of any cloning kit or specialized enzyme for cloning. Furthermore, with
reduced number of PCR cycles, it also decreases the chance of random mutations. In addition, this method is
highly effective and reproducible. Finally, since this cloning method is also sequence independent, we
demonstrated that it can be used for chimera construction, insertion, and multiple mutations spanning a stretch of
DNA up to 120 bp.
Conclusion: Our FastCloning technique provides a very simple, effective, reliable, and versatile tool for molecular
cloning, chimera construction, insertion of any DNA sequences of interest and also for multiple mutations in a
short stretch of a cDNA.

Background
Molecular cloning is one of the most widely used techniques in biomedical research laboratories. Traditionally,
molecular cloning joins insert and vector by T4 DNA
ligase after restriction digestion to excise insert from a
donor vector or from a PCR product with restriction
enzyme recognition sites added to the ends [1]. Although
this is a widely used method, it involves multiple steps and
is time consuming. This multi-step process also makes it
difficult or complicated for troubleshooting. To overcome
the difficulties encountered in the original cloning method,
many other alternative cloning methods have been developed over the last two decades. These methods include
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TA cloning [2], ligation independent cloning with T4
DNA polymerase [3,4], GATEWAY recombinational cloning [5], and more recent sequence- and ligation-independent cloning kits, such as CloneEZ (GenScript USA Inc.,
Piscataway, NJ, USA), one step cloning [6], and overlap
extension PCR cloning [7]. However, each of these techniques has its own limitations. For example, TA cloning
uses regular Taq DNA polymerase to add a single 3’-A
overhang to the ends of the PCR product. The PCR product is directly cloned into a TA cloning vector with a
complementary 3’-T overhang in both ends without
restriction digestion. The limitations of this method are
low fidelity of Taq DNA polymerase causing unwanted
mutations and requirement of subcloning into the final
target vector with restriction digestion and ligation. The
early ligation independent cloning uses the 3’-exonucnease
activity of T4 DNA polymerase to create 15-base
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5’overhangs in the ends of insert and complementary 5’
overhangs in the ends of vector. This technique requires
specific sequences to create 15-base overhangs. Gateway
recombinational cloning uses site-specific recombination
to transfer cDNAs between donor and destination vectors,
which requires additional specific sequences for recombination. The latest ligation-independent cloning, such as
CloneEZ and In-Fusion cloning kits, uses some DNA polymerase to generate sticky ends in the vector and insert
without specific sequence requirement, except for restriction sites to linearize the vector. However, the new ligation
independent cloning still requires purification of the
digested vector and PCR-amplified insert, and the purchase of purification and cloning kits. Similarly, overlap
extension PCR cloning also requires purification of the
first round PCR products (vector and insert) and an additional round overlap extension PCR, which usually generates multiple bands, for producing linked vector and
insert. One-step “quick assemble” cloning does not need
purification of PCR products. However, it includes two
sequential 35-cycle PCRs with a total number of 70 cycles.
The first-round PCRs are used to amplify insert and linear
vector. The second-round PCR is essentially the overlap
extension PCR to assemble vector and insert into a single
linear PCR product. Another ligation independent cloning
technique, using nick DNA endonuclease to create long
single-strand 5’ overhangs in the vector and PCR-amplified insert [8], requires specific sequences for nick DNA
endonuclease and purification of the PCR product.
Purification of PCR product not only takes extra time
and requires purification kit, but also potentially creates
additional problems. For example, to compensate for the
loss of PCR product during purification, the number of
PCR cycles is generally 25-30. High number of PCR cycles
increases the chance of random mutations or, in our
experiences, dramatically decreases cloning efficiency for
the PCR products generated by high fidelity DNA polymerases. This is especially true for the enzyme with high
processability, such as pfuUltraII DNA polymerase. The
decrease in cloning efficiency cannot be completely overcome by using state-of-the-art cloning kits, such as CloneEZ. Using this kit (with gel purification of digested
vectors and PCR-amplified inserts), the successful rate in
our laboratory still varies significantly with overall successful rate less than 50%. In the PCR-based QuickChange
mutagenesis, the number of PCR cycles is recommended
to be 12-18. Increase in PCR cycles could decrease efficiency according to the QuickChange protocol. Thus,
these phenomena made us believe that the proofreading
PCR enzymes could potentially damage the ends of PCR
products if the number of PCR cycles increases. This
could be due to the fact that the high fidelity DNA polymerases with the proofreading ability have 3’ exonuclease
activity. In the presence of dNTPs, the ends of PCR
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products can be protected from this 3’ exonuclease activity. It is possible that depletion of dNTPs in high number
of PCR cycles or dilution of dNTPs in the early stage of
purification would weaken the 3’ ends protection against
3’ exonuclease activity of the DNA polymerase, which
results in the damage of PCR products and makes cloning
extremely difficult.
To circumvent the above-mentioned problems, we
developed a cloning method termed FastCloning. With
this method, both insert and vector are amplified by 18
PCR cycles with a high fidelity DNA polymerase. The
unpurified PCR products of the vector and insert are then
directly mixed at some ratios (see below) and digested by
DpnI restriction enzyme to destroy their methylated DNA
templates. Finally, the digested mixture is transformed
into competent cells to obtain the target clones. The PCR
amplification of vector is designed to make it possible to
clone an insert into any position of the vector, to bypass
vector digestion (and restriction site limitation) and purification steps, and to be compatible with DpnI digestion of
the insert without further inactivation of the enzyme.
Thus, this method can be used to construct cDNAs of
fusion proteins or chimera without limitation by available
restriction sites. In this study, we experimentally validated
all these applications with our new method. In addition, a
similar method can be easily adapted for deletion of a
DNA fragment.

Methods
Figure 1 illustrates the highly simplified procedure of our
FastCloning method. Briefly, after gel confirmation of PCR
products, the remaining unpurified PCR reactions, containing amplified vector and insert, are mixed and digested
with DpnI for 1 hour at 37°C. The digested mixture is
then directly transformed into chemically competent Stratagene XL-10 Gold or NEB 10-beta E. coli cells.
The primers were designed with Oligo Analyzer 1.5
(http://www.genelink.com) to have an annealing temperature around 60°C (Nearest Neighbor method). The forward primer for vector amplification is in the 3’ side of the
polylinker region. The reverse primer for vector amplification is in the 5’ side of the polylinker, and its reverse and
complementary sequence was generated by Oligo Explorer
1.5. The primers for insert amplification have insert-specific sequences and additional 15-17 bases (depending on
the GC content) overlapping with the vector ends. The
specific sequences of primers used in this study are listed
in Table 1. All the primers used in this study were synthesized by Invitrogen Corporation (Carlsbad, CA).
The PCR reaction components were: 50 μl total
volume, 0.5 μl Phusion DNA polymerase (New England
Biolabs, Ipswich, MA), or 0.8 μl Pfu Turbo, or PfuUltra
DNA polymerase (Agilent Technologies, Inc, Santa
Clara, CA), 5 μl 10× buffer; 5 μl of 2.5 mM dNTPs;
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Step 1: PCR amplification of vector and insert

Vector

Insert

Step 2: DpnI digestion of DNA templates

Digested
template

Digested
template

Vector

Insert

Step 3: Transformation into competent cells

Figure 1 The procedures for FastCloning: Step 1. PCR amplification of vector and insert. Note that the primer pair for insert amplification has
16-base tails overlapping with the PCR-amplified vector ends. Step 2. DpnI digestion. The parent DNA templates (if in a plasmid) for PCR
amplification needs to be methylated in order to be compatible to DpnI digestion. Although the detailed mechanism is not known, it is likely
that the 3’ exonuclease activity of the high fidelity DNA polymerase directly creates sticky ends for the overlapped regions of the vector and
insert during DpnI digestion, allowing them to form a circular construct with nicks. Step 3. transformation into competent E. coli. cells. The nicks
will be repaired after transformation into the bacteria.

10 ng of plasmid DNA template; 5 pmol of each primer.
The PCR cycling parameters were 98°C 3 min, (98°C 10
sec, 55°C 30 sec, 72°C 20 sec/kb) × 18 cycles, 72°C 5
min, and 4°C infinite for Phusion DNA polymerase, and
95°C 3 min, (95°C 15 sec, 55°C 1 min, 72°C 1 min/kb) ×

18 cycles, 72°C 5 min, and 4°C infinite for Pfu Turbo or
PfuUltra DNA Polymerase. The PCR products (5 μl for
each product) were examined with 1% agarose gel electrophoresis with ethidium bromide staining using VWR
Mini Gel electrophoresis setup (VWR International,
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Table 1 Primers used in the cloning or mutagenesis experiments
Primer name

Primer description

Primer sequence

pGEMHEStartRev

Reverse primer for pGEMHE vector with start codon

CATGGCCAAAGTTGAGCGTTTATTCTG

pGEMHEStopFwd

Forward primer for pGEMHE vector with stop codon

TAAACCAGCCTCAAGAACACC

p3X14startRV

Reverse primer for p3xFlag-cmv-14 vector with start codon

CATGGTGGCGAATTCGCGGCCGCAAGC

p3X14endFW

Forward primer for p3xFlag-cmv-14 vector

GGATCCCGGGCTGACTAC

CHRNA9Startez

Forward primer for CHRNA9 cloning into pGEMHE

CTCAACTTTGGCCATGAACTGGTCCCATTCCTGCAT

CHRNA9Stopez

Reverse primer for CHRNA9 cloning into pGEMHE

TCTTGAGGCTGGTTTAATCCGCTCTTGCTATGATCAAA

CHRNB2qk5

Forward primer for CHRNB2 cloning into pGEMHE

GCTCAACTTTGGCCATGGCCCGGCGCTGCGG

CHRNB2qk3
CHRNA4_qk5

Reverse primer for CHRNB2 cloning into pGEMHE
Forward primer for CHRNA4 cloning into pGEMHE

TTCTTGAGGCTGGTTTACTTGGAGCTGGGGGCTG
GCTCAACTTTGGCCATGGAGCTAGGGGGCCC

CHRNA4_qk3

Reverse primer for CHRNA4 cloning into pGEMHE

TTCTTGAGGCTGGTTTAGATCATGCCAGCCAGCC

ECSM2_qk5

Forward primer for ECSCR cloning into pGEMHE

GCTCAACTTTGGCCATGGGCACCGCAGGAGC

ECSM2_qk3

Reverse primer for ECSCR cloning into pGEMHE

TTCTTGAGGCTGGTTTAAAGAACCTTCTCTGCTGAGAG

HEstartFW-p3X14

Forward primer for ECSCR cloning into p3xFlag-cmv-14

CGAATTCGCCACCATGGGCACCGCAGGAGC

HEendRV-p3X14

Reverse primer for ECSCR cloning into p3xFlag-cmv-14

AGTCAGCCCGGGATCCAAGAACCTTCTCTGCTGAGAG

ZACNqk5

Forward primer for ZACN cloning into pGEMHE

GCTCAACTTTGGCCATGATGGCCCTATGGTCCCTG

ZACNqk3
APBB1qk5

Reverse primer for ZACN cloning into pGEMHE
Forward primer for APBB1 cloning into pGEMHE

TTCTTGAGGCTGGTTTACAGTCTAGGCCGCCTGC
GCTCAACTTTGGCCATGTCTGTTCCATCATCACTGAG

APBB1qk3

Reverse primer for APBB1 cloning into pGEMHE

TTCTTGAGGCTGGTTTATGGGGTATGGGCCCCCA

HTR3A5P381_5A5

Forward primer of HTR3A for 5 Pro mutated to Ala

CGCTGCCGCAGCAGCTCGGGAGGCCTCGCTG

HTR3A5P381_5A3

Reverse primer of HTR3A for 5 Pro mutated to Ala

GAGCTGCTGCGGCAGCGCTACATCTGTCCCTCGGG

pLXSN3’fwd

Forward primer for pLXSN vector

GGATCCGGCTGTGGAATGTG

pLXSN5’rev

Forward primer for pLXSN vector

GAATTCCGGCGCCTAGAGAA

Akt3v1&2Start

Forward primer for Akt3v1 & v2 with Kozak sequence

CTAGGCGCCGGAATTCCATCATGAGCGATGTTACCATTGTG

Akt3v1StopRev
Akt3v2StopRev

Reverse primer for Akt3v1 cloning into pLXSN
Reverse primer for Akt3v2 cloning into pLXSN

TTCCACAGCCGGATCCTTATTCTCGTCCACTTGCAGAGTAG
TTCCACAGCCGGATCCTTATTTTTTCCAGTTACCCAGCATGC

b2b4N_Rv

Reverse primer for vector along with N-terminal cDNA

GATGATGAGGTTGATGGTGTAG

b2b4C_Fw

Forward primer for insert amplification

CATCAACCTCATCATCCCCTG

b2StopRv_HE

Reverse primer for C-terminal b2 insert amplification

CTTGAGGCTGGTTTACTTGGAGCTGGGGGCTG

b4StopRv_HE

Reverse primer for C-terminal b4 insert amplification

AChBPins1Fw

Forward primer for AChBP insert1 to a7 nAChR

CTTGAGGCTGGTTTAGTCACGCTGGGCAGCGT
CCCGGCCCCACCAAGGACGACCCCCTGACCGTGACCCTGGG
CTTCACCCTGCAGGACATCATGGACGTGGATGAGAAGAAC

AChBPins1Rv

Reverse primer for AChBP insert1 to a7 nAChR

CTTGGTGGGGCCGGGGTACATGGGGCTTCTGTTGAACA
GGTCGCTCTTCAGTCTCATCTGGAACTCGCCTTGCAGG

AChBPins2Fw

Forward primer for AChBP insert2 to a7 nAChR

TGTGGGACCCCAACGAGTACGGCAACATCACCGACTTCAGA
ACCAGCGCCGCCGACATTTGGAAACCAGACATTCTTCTCTA

AChBPins2Rv

Reverse primer for AChBP insert2 to a7 nAChR

TCGTTGGGGTCCCACATCAGGCTGTTCAGCTTCCATCTCT
GCTGCTCGTAGTACACGGTGGTTAAAACTTGGTTCTTCTC

AChBPins3Fw

Forward primer for AChBP insert3 to a7 nAChR

TCGCCGTGGTGACCCACGACGGCAGCGTGATGTTCATCCCCG
CCCAGAGACTGAGCTTCATGTGCTACATCGATGTACGCTGG

AChBPins3Rv

Reverse primer for AChBP insert3 to a7 nAChR

TGGGTCACCACGGCGATCTGGGGGCTCAGCACCTGCACGGGTC
TGGTGCTGCTGTAGGCGGTAATGTCTGGTTTCCAAATGTCGG

AChBPins4Fw

Forward primer for AChBP insert4 to a7 nAChR

CTTCGAGATCGACCTGAAGACCGACACCGA
CCAGGTGGATATCAGTGGCTATATCCCCA

AChBPins4Rv

Reverse primer for AChBP insert4 to a7 nAChR

CAGGTCGATCTCGAAGCCGCTGTACACCCAGCTG
CCGAACTTCACGGCGCAGTGCTGCACATCAAAGG

AChBPins5Fw

Forward primer for AChBP insert5 to a7 nAChR

TACAGCTGCTGCCCCGAGCCCTACATCGACGTGAA
CCTGGTGGTGAAGTTCCGCCGCAGGACACTCTAC

AChBPins5Rv

Reverse primer for AChBP insert5 to a7 nAChR

CGGGGCAGCAGCTGTAGTGCTGCACCTGTCTGGTCT
GGGTGGCGCTCAGGATGTCCCATTCTCCATTGGGGA

Marietta, GA, USA) running at 100 V for 30 min. The
PCR products were then visualized under a UV transilluminator, and gel pictures were taken using an AGFA
scanner.

After confirmation of PCR products, 1 μl of DpnI
enzyme (New England Biolabs) was added into the
remaining unpurified PCR reactions (45 μl for each product) for vector or insert separately. The vector and
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insert were then mixed with 1:1 ratio (1:1, 1:2, and 1:4
for a9 nAChR subunit), and digested at 37°C for
1 hour. Two micro-liters (2, 4, and 8 μl for a9 nAChR)
of the digested vector-insert mixture were then added to
40 μl of chemically competent XL-10 Gold E. coli cells
(prepared with rubidium chloride method) unless indicated otherwise. The mixture was then incubated for
30 min on ice. After heat shock at 42°C for 45 sec,
350 μl of SOC medium was added to the mixture. After
60 min shaking at 37°C and 350 rpm with an Eppendorf
Thermomixer, the entire content was plated onto the
LB agar plate containing 100 μg/ml ampicillin. The
plates were then incubated at 37°C overnight. Next day,
colonies from each constructs were picked for PCR confirmation of each construct using GoTaq DNA polymerase (Promega, Madison, WI, USA) and vector specific
primers, and also for inoculation in the LB medium
(with ampicillin) for overnight culture of each clone for
mini-prep. The DNA mini-prep was performed using
QIAprep Spin Miniprep Kit (QIAGEN, Valencia, CA,
USA). All the cloned sequences were finally confirmed
by automated DNA sequencing at the DNA lab of the
Arizona State University using primers in the vectors.
Figure 2 illustrates the application of this method to
construct cDNAs encoding chimeric or fusion proteins. In
this case, the PCR amplification of the vector also includes
part of the cDNA in both ends. To insert a cDNA encoding a full-length protein, such as green fluorescence protein, the insert amplification should cover the entire
coding region of the cDNA. For homologous domain
swap chimera, insert amplification only needs to cover the
corresponding region of a cDNA encoding a homologous
fragment of protein. The detailed experimental procedures
for chimera construction are essentially the same as
cloning.
For insertion (or substitution) of a short DNA fragment
(< 120 bp), the insert can be directly included in the primer sequences for vector amplification (Figure 3). This is
a very convenient way to insert a short tag (such as myc
tag or FLAG-tag) or to replace a short DNA fragment for
chimera construction without limitation of the availability
of specific DNA template for the insert. Introducing multiple mutations in a short (up to 120 bp) stretch of a cDNA
is equivalent to replacing a short DNA fragment for chimera construction.

Results and Discussion
As a proof of principle, we subcloned several cDNAs
into different vectors (human nicotinic receptor
(nAChR) a4, a9 and b2 subunits, and serotonin receptor type 3A (5-HT3A) subunit into the pGEMHE vector,
human endothelial cell-specific molecule 2 (ECSM2)
into the p3XFLAG-CMV-14 vector, and Akt3v1 or
Akt3v2 into pLXSN vector). pGEMHE is a vector
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containing 5’ and 3’ untranslated regions (5’UTR and
3’UTR) of Xenopus b-globin, which is highly expressed
in Xenopus oocytes. With this vector, the protein
expression level of the inserted gene in Xenopus oocyte
can be increased by up to 200-fold [9].
We first optimized cloning conditions by cloning a9
nAChR subunit cDNA into the pGEMHE vector. Figure
4A is an example of agarose gel electrophoresis for verification of PCR products of the vector (pGEMHE) and
insert (a9 nAChR). In each lane, 5 μl of PCR products
was loaded. Note that amplification efficiency is the highest for Phusion DNA Polymerases and lowest for Pfu
Turbo. We then compared cloning efficiency, in terms of
number of colonies produced after transformation, for
optimal ratio of vector and insert during DpnI enzyme
digestion and optimal amount of the vector-insert mixture used in transformation. Vectors and inserts were
mixed with three different ratios (1:1, 1:2, and 1:4 with a
total volume of 16 μl), and incubated at 37°C for 1 h. Different amounts (2, 4, and 8 μl) of the DpnI-digested mixtures were then added into 40 μl of chemically
competent XL-10 Gold E.coli cells for transformation.
The number of colonies that grew on each plate was
counted next day. Figure 4B shows the number of colonies that resulted from different DNA polymerases, vector to insert ratios (1:1, 1:2, and 1:4), and the amount of
vector-insert mixture (2 μl, 4 μl, and 8 μl) used for transformation. The results suggest that the best combination
for colony formation is Phusion DNA polymerase amplification with 1:1 vector/insert ratio in DpnI digestion and
2 μl of vector-insert mix for transformation. Four colonies from the plates resulting from each DNA polymerase were picked up for DNA mini-prep. The PCR
confirmation of the insert in the target vector (Figure 4C)
was performed with the GoTaq DNA polymerase (Promega Corporation, Madison, WI) using the pGEMHE
vector specific primer pair. Our results indicated that >
90% colonies (11 out of 12) were positive. We have also
compared colony production efficiency for three different
numbers of PCR cycle (12, 18, and 24 cycles) and three
different durations (1, 2, and 4 hours) of incubation time
for 37°C DpnI digestion with a9 nAChR cDNA cloned
into pGEMHE and transformed into NEB 10-beta high
efficiency competent E coli. The result shows that the 18cycle PCR amplification of vector and insert produced
many more colonies than the 12-cycle and 24-cycle
amplifications (31, 302, 43 colonies for 12, 18, and 24
cycles respectively). For incubation duration in DpnI
digestion, 1, 2, and 4 hours of incubation had similar
colony production efficiency with colony numbers of
281, 263, and 285 for 1, 2, and 4 hour-incubations,
respectively). However, shorter incubation time is not
recommended. In our QuickChange mutagenesis experiment, 30 min incubation in DpnI digestion could not
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PCR

DpnI digestion

Transformation

Figure 2 Chimera construction or insertion. Top left: PCR amplification of both ends of the parent cDNA along with the vector. For chimera
construction, one fragment of the cDNA needs to be replaced. Thus, the forward primer is immediately downstream of the fragment to be
substituted, and the reverse primer will be immediately upstream of the fragment to be substituted. For insertion, however, two primers will be
next to each other without skipping a single base. Top right: Insert amplification of the equivalent region of a homologous gene (cDNA) for
chimera construction. However, for insertion of a cDNA encoding a full length protein, such as green fluorescent protein, the insert amplification
will cover the entire cDNA. The remaining procedure is the same as in Figure 1.

adequately remove the wild-type template background
and resulted in a significantly higher fraction of wild type
constructs.
In addition, the PCR-based method could produce
some unusual constructs. In our > 10-year practice with
the QuickChange site-directed mutagenesis, we only
encountered an unusual recombination once. With our
FastCloning method in the past few months, we have
not seen any unusual construct yet. Thus, if our cloning
method produces unusual constructs, their occurrence

must be very low. Figure 4D is an example of using
restriction digestion to screen clones to exclude unusual
constructs. It would be a good practice to perform such
a screening for all resulting clones before DNA sequencing. With the optimized cloning conditions (Phusion
DNA polymerase, 1:1 vector/insert ratio, 18 cycle PCR
amplification, 2 μl of vector-insert mix for transformation, and 1 hour DpnI digestion), we have also successfully cloned other cDNAs into the target vectors, and
obtained positive clones at efficiency ranging from 43%
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up to 120 bp
15-17bp overlap

PCR

DpnI digestion

Transformation

Figure 3 Chimera construction or insertion with a short DNA
fragment. To replace a short stretch of DNA, such as a DNA
fragment encoding a transmembrane region of a nAChR subunit for
chimera construction, or to insert a short tag, such as FLAG-tag, into
some part of a protein, amplification of the insert is not necessary.
In this case, the insert can be directly included in two primers for
single PCR amplification of the cDNA along with the vector. The
forward primer starts immediately downstream of the insertion site
and has a tail with the 3’ part of the insert. The reverse primer starts
immediately upstream of the insertion site and has a tail with 5’
part of the insert. Two primers only require ~16-base overlap. Thus,
for a 120 bp insertion, each primer needs to have a 68-base tail for
insertion and ~17-22 bases for annealing (depending on the GC
content). The total length of each primer will be about 85-90 bases.
DpnI digestion and transformation are the same as in Figure 1.

to 100%, with an overall efficiency > 70%. The results
further validate the versatility and reliability of this new
technique.
Because the PCR amplification of vector can be controlled by primers to exact positions, our FastCloning
method is truly sequence-independent. Thus, one can
put an insert to any position and in any frame. This feature, although with only a small modification of
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standard cloning protocol, makes it easy to construct
cDNAs for fusion proteins or chimeras. Furthermore, a
minor variation of this technique can be applied for
insertion of a short DNA fragment directly from two
relative long primers for PCR amplification of a cDNA
along with its vector. As a proof of principle, we have
successfully created human nAChR cDNAs encoding
b2-b4 chimeric subunit proteins with C-terminal
domain swap between the b2 and b4 subunits. We have
also successfully inserted DNA fragments into cDNAs
using two long primers with a 16-base overlapping
region to directly amplify the cDNA. Figure 5 is an
example of using a synthesized insert (99 bp), a DNA
sequence encoding a fragment of an acetylcholine binding protein (AChBP), to replace a DNA fragment in the
cDNA of the human a7 nAChR for chimera construction. Note that each primer contains only slightly more
than half of the insert. The primer pairs have a 16-base
overlap region. Using similar method, we have successfully replaced other four DNA fragments (105 bp, 90 bp,
69 pb, and 87 pb) in human a7 nAChR with synthetic
AChBP fragments and swapped the DNA sequences
(66 bp) encoding the second transmembrane domains of
human a4 and b2 nAChR subunits.
Making multiple mutations in a stretch of DNA is
equivalent to making short insertions. Figure 6 is an example of 8 amino acid substitutions (8 arginines to 8 glutamines) with multiple nucleotide mutations spanning a 13codon region in the cDNA encoding human nAChR b2
subunit. With this relatively short primer pair (45-base
forward primer and 46-base reverse primer), we have
successfully obtained this multiple mutations spanning a
13-codon stretch in the cDNA. In addition, we have successfully made a quintuple mutant (5 consecutive prolines
mutated to 5 alanines) of human 5-HT3A receptor subunit
with a 31-base forward primer and 35-base reverse primer.
It is important to be aware that with PCR-based cloning,
the synthesized primers may not be completely uniform
with correct sequences. Random single-base deletions,
mutations, or insertions can occur in a small fraction of
primers, which result in unwanted deletion/mutation/
insertion in a small fraction (< 5%) of clones. This is especially true for short insertion with long primers. Thus,
sequencing across the primer region is required for ultimate confirmation of each clone. If random mutation happens in one clone, picking up another clone often solve
the problem. The random mutation out of primer region
is rare with high fidelity DNA polymerases. However,
DNA sequencing of the entire coding region is still necessary. In the past 8 months, we have successfully used our
new cloning method to obtain 21 constructs. Among the
63 sequenced clones, we found 2 deletions in 2 chimeras
constructed with long primer pairs, but found no mutations in the entire regions of all constructs beyond
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Figure 4 Optimization of cloning conditions. (A) PCR amplification of a target cDNA (human nAChR a9 subunit) and the pGEMHE vector
using different DNA polymerases: Pfu Turbo, PfuUltra and Phusion. (B) Comparison of number of colonies grown on the plates after
transformation. Three different vector-to-insert ratios (1:1, 1:2, and 1:4) during DpnI digestion and three amounts of vector-insert mixtures (2, 4,
and 8 μl) for transformation were tested. See text for details. (C) Clone validation by PCR using GoTaq DNA polymerase. Lanes 1 to 12: target
clones to be validated; Lane 13: 1 Kb plus DNA ladder; Lane 14: pGEMHE vector control; Lane 15: negative control using pCR4-TOPO-a9 parent
plasmid. (D) Clone validation by restriction digestion to exclude unusual constructs. Lane 1: 1 Kb plus DNA ladder, Lanes 2-11: target clones
double digested with KpnI and NheI. Note that this digestion resulted in a pGEM vector and an insert with a9 nAChR plus the 5’UTR and 3’UTR
of Xenopus b-globin.
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Wild-W\SHKXPDQQ$&K5Į
CTGCACGTGTCCCTGCAAGGCGAGTTCCAGAGGAAGCTTTACAAGGAGCTGGTCAAGAACTACAATCCCTTGGAGAGGCCC
GACGTGCACAGGGACGTTCCGCTCAAGGTCTCCTTCGAAATGTTCCTCGACCAGTTCTTGATGTTAGGGAACCTCTCCGGG
L H V S L Q G E F Q R K L Y K E L V K N Y N P L E R P
GTGGCCAATGACTCGCAACCACTCACCGTCTACTTCTCCCTGAGCCTCCTGCAGATCATGGACGTGGATGAGAAGAACCAA
CACCGGTTACTGAGCGTTGGTGAGTGGCAGATGAAGAGGGACTCGGAGGACGTCTAGTACCTGCACCTACTCTTCTTGGTT
V A N D S Q P L T V Y F S L S L L Q I M D V D E K N Q

B
C

AChBP
nAChR 7

QANLMRLKSDLFNRSPMYPGPTKDD--PLTVTLGFTLQDIVKVDSSTNEV
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:* .:*.:.
*. :* **** :.::* :*:.**...: :

AChRĮ7-AChBP chimera %ODFNQ$&K5ĮVHTXHQFH5HGAChBP sequence)
CCTGCAAGGCGAGTTCCAGATGAGACTGAAGAGCGACCTGTTCAACAGAAGCCCCATGTACCCCGGCCCCACCAAGGAC
GGACGTTCCGCTCAAGGTCTACTCTGACTTCTCGCTGGACAAGTTGTCTTCGGGGTACATGGGGCCGGGGTGGTTCCTG
L

Q
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Q
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Reverse primer
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P

T

K

D

Forward primer
GACCCCCTGACCGTGACCCTGGGCTTCACCCTGCAGGACATCATGGACGTGGATGAGAAGAAC
CTGGGGGACTGGCACTGGGACCCGAAGTGGGACGTCCTGTAGTACCTGCACCTACTCTTCTTG
D P L T V T L G F T L Q D I M D V D E K N
Figure 5 An example of chimera construction with a short (105 bp) DNA fragment replaced by a synthesized insert of 99 bp
(included in two primers). (A) A region of a7 nAChR subunit sequence with a 105 bp fragment (blue) to be replaced. (B) Amino acid
sequence alignment of human a7 nAChR and corresponding region of Aplysia californica AChBP. Segments to be replaced are colored with blue
(35 codons) for a7 nAChR sequence and red (33 codons) for AChBP sequence. (C) Target chimera construct with the human nAChR a7 subunit
sequence (black) and a substituted 99 bp DNA fragment (red) from the mammalian codon-optimized homologous sequence of the AChBP. Two
colored arrows indicate two primers with a 15 bp overlapping region (highlighted). Note that the entire insert of the 99 bp fragment is included
in the two primers. Thus, there is no need to amplify the insert. The length of each primer is 81 bases for the forward primer and 76 bases for
the reverse primer.

A

Wild-type nAChRE2 :
CCACGCCATCATTGCGCCCGTCAGCGCCTGCGCCTGCGGCGACGCCAGCGTGAGCGCGAGGGCGCTGGAGCCCTC
P R H H C A R Q R L R L R R R Q R E R E G A G A L
nAChRE2- 8Rto8Q mutant:
CCACGCCATCATTGCGCCC AACAGCAGCTGCAACTGCAGCAACAGCAGCAGGAGCAAGAGGGCGCTGGAGCCCTC
P R H H C A Q Q Q L Q L Q Q Q Q Q E Q E G A G A L

B

Primer pair to generate the nAChRE2 - 8Rto8Q mutant:
Forward primer
CAACTGCAGCAACAGCAGCAGGAGCAAGAGGGCGCTGGAGCCCTC
GGTGCGGTAGTAACGCGGG TTGTCGTCGACGTTGACGTCGTTGTCG
Reverse primer

Figure 6 An example of making multiple mutations across a wide region. (A) A fragment of the human nAChR a2 subunit cDNA with 8
arginine (R, in bold) codons (top) to be substituted by glutamine (Q) codons (bottom). Mutated nucleotides are indicated in red. (B) Actual
forward (45-base) and reverse (46-base) primers with 16 bp overlapping in their 5’ ends.
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primers. Finally, the cloning efficiency of our FastCloning
method is high. Of the 21 cloning constructs, we obtained
19 desired constructs in single runs. In 2 experiments, we
needed to repeat the procedure to get the final clones.
With only one additional construct, we have not obtained
final clones after two attempts.

Conclusion
We have developed a highly simplified and robust PCR
cloning technique termed FastCloning. The new technique eliminates the need of PCR purification/gel purification kit and cloning kit. It is ligation-independent and
does not require specific sequence in the vector. Thus,
one can insert a DNA fragment into a vector at any
desired position without considering restriction sites.
This feature also makes it extremely easy to make constructs for fusion proteins and chimeras. In addition, it
can be used to make short insertions and multiple
mutations spanning a wide region (up to 120 bp) in a
cDNA. Finally, it is a highly efficient and reproducible
method.

Page 10 of 10

References
1. Sambrook J, Russell D: Molecular Cloning: A Laboratory Manual. Cold
Spring Harbor Laboratory Press, New York; 2001.
2. Marchuk D, Drumm M, Saulino A, Collins F: Construction of T-vectors, a
rapid and general system for direct cloning of unmodified PCR
products. Nucleic Acids Research 1991, 19:1154.
3. Aslanidis C, de Jong P: Ligation-independent cloning of PCR products
(LIC-PCR). Nucleic Acids Research 1990, 18:6069-6074.
4. Haun R, Serventi I, Moss J: Rapid, reliable ligation-independent cloning of
PCR products using modified plasmid vectors. BioTechniques 1992,
13:515-518.
5. Walhout A, Temple G, Brasch M, Hartley J, Lorson M, van den Heuvel S,
Vidal M: GATEWAY recombinational cloning: application to the cloning
of large numbers of open reading frames or ORFeomes. Methods in
Enzymology 2000, 328:575-592.
6. Zuo P, Rabie B: One-step DNA fragment assembly and circularization for
gene cloning. Current Issues in Molecular Biology 2009, 12:11-16.
7. Bryksin A, Matsumura I: Overlap extension PCR cloning: a simple and
reliable way to create recombinant plasmids. BioTechniques 2010,
48:463-465.
8. Yang J, Zhang Z, Zhang X, Luo Q: A ligation-independent cloning method
using nicking DNA endonuclease. BioTechniques 2010, 49:817-821.
9. Liman E, Tytgat J, Hess P: Subunit stoichiometry of a mammalian K+
channel determined by construction of multimeric cDNAs. Neuron 1992,
9:861-871.
doi:10.1186/1472-6750-11-92
Cite this article as: Li et al.: FastCloning: a highly simplified, purificationfree, sequence- and ligation-independent PCR cloning method. BMC
Biotechnology 2011 11:92.
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PCR: polymerase chain reaction; nAChR: nicotinic acetylcholine receptor;
AChBP: acetylcholine binding protein; CHRNA9: gene name of the human
nAChR α9 subunit; CHRNA4: gene name of the human nAChR α4 subunit;
CHRNB2: gene name of the human nAChR β2 subunit; 5-HT3A: serotonin
receptor type 3 A subunit; HTR3A: the gene name for human 5-HT3A
receptor subunit; ECSM2: endothelial cell specific molecule 2 (also named
ECSCR: endothelial cell-specific chemotaxis regulator); AChBP: acetylcholine
binding protein; Akt3v1/v2: protein kinase B gamma variant 1 or 2; ZACN:
gene name of the human zinc activated cation channel
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